Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production

Seminars in Immunology

Volumn 18, Issue 5, 2006, Pages 290-296

  Kalled, Susan L ^a  

^a BIOGEN   (United States)

Author keywords

B cell; BAFF; BAFFR; BR3; Immunity

Indexed keywords

ANTIBODY; B LYMPHOCYTE ACTIVATING FACTOR; B LYMPHOCYTE ACTIVATING FACTOR RECEPTOR 3; B LYMPHOCYTE RECEPTOR; CELL SURFACE MARKER; IMMUNOGLOBULIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CELL FRACTIONATION; CELL LINEAGE; CELL MATURATION; CELL SELECTION; CELL SURVIVAL; CYTOLOGY; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRE B LYMPHOCYTE; PRIMATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; VALIDATION STUDY;

ANIMALS; ANTIBODY FORMATION; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CELL SURVIVAL; GERMINAL CENTER; HUMANS; LEUKEMIA, B-CELL; LYMPHOCYTE COOPERATION; LYMPHOMA, B-CELL; MICE; PRIMATES; SPECIES SPECIFICITY;

EID: 33748638386     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2006.06.002     Document Type: Review

References (69)

1. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285 5425 (1999) 260-263
2. Kalled S.L., Ambrose C., and Hsu Y.M. The biochemistry and biology of BAFF, APRIL and their receptors. Curr Dir Autoimmun 8 (2005) 206-242
3. Cachero T.G., Schwartz I.M., Qian F., Day E.S., Bossen C., Ingold K., et al. Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). Biochemistry 45 7 (2006) 2006-2013
4. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189 11 (1999) 1747-1756
5. Nardelli B., Belvedere O., Roschke V., Moore P.A., Olsen H.S., Migone T.S., et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97 1 (2001) 198-204
6. Huard B., Arlettaz L., Ambrose C., Kindler V., Mauri D., Roosnek E., et al. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol 16 3 (2004) 467-475
7. Scapini P., Nardelli B., Nadali G., Calzetti F., Pizzolo G., Montecucco C., et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med 197 3 (2003) 297-302
8. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3 9 (2002) 822-829
9. Hase H., Kanno Y., Kojima M., Hasegawa K., Sakurai D., Kojima H., et al. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 103 6 (2004) 2257-2265
10. Zhang X., Park C.S., Yoon S.O., Li L., Hsu Y.M., Ambrose C., et al. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol 17 6 (2005) 779-788
11. Gorelik L., Gilbride K., Dobles M., Kalled S.L., Zandman D., and Scott M.L. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 198 6 (2003) 937-945
12. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201 2 (2005) 195-200
13. Nishio M., Endo T., Tsukada N., Ohata J., Kitada S., Reed J.C., et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106 3 (2005) 1012-1020
14. Ohata J., Zvaifler N.J., Nishio M., Boyle D.L., Kalled S.L., Carson D.A., et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 174 2 (2005) 864-870
15. Moreaux J., Cremer F.W., Reme T., Raab M., Mahtouk K., Kaukel P., et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106 3 (2005) 1021-1030
16. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 109 1 (2002) 59-68
17. Lavie F., Miceli-Richard C., Quillard J., Roux S., Leclerc P., and Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. J Pathol 202 4 (2004) 496-502
18. Ittah M., Miceli-Richard C., Eric Gottenberg J., Lavie F., Lazure T., Ba N., et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res Ther 8 2 (2006) R51
19. Dillon S.R., Gross J.A., Ansell S.M., and Novak A.J. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5 3 (2006) 235-246
20. Novak A.J., Bram R.J., Kay N.E., and Jelinek D.F. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100 8 (2002) 2973-2979
21. He B., Chadburn A., Jou E., Schattner E.J., Knowles D.M., and Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 172 5 (2004) 3268-3279
22. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293 5537 (2001) 2108-2111
23. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol 11 19 (2001) 1547-1552
24. Gras M.P., Laabi Y., Linares-Cruz G., Blondel M.O., Rigaut J.P., Brouet J.C., et al. BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int Immunol 7 7 (1995) 1093-1106
25. von Bulow G.U., and Bram R.J. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278 5335 (1997) 138-141
26. Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 112 2 (2003) 286-297
27. Gorelik L., Cutler A.H., Thill G., Miklasz S.D., Shea D.E., Ambrose C., et al. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J Immunol 172 2 (2004) 762-766
28. Ng L.G., Sutherland A.P., Newton R., Qian F., Cachero T.G., Scott M.L., et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 173 2 (2004) 807-817
29. Novak A.J., Darce J.R., Arendt B.K., Harder B., Henderson K., Kindsvogel W., et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 103 2 (2004) 689-694
30. Moreaux J., Legouffe E., Jourdan E., Quittet P., Reme T., Lugagne C., et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103 8 (2004) 3148-3157
31. Smith S.H., and Cancro M.P. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature b cells and their immediate progenitors. J Immunol 170 12 (2003) 5820-5823
32. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 11 (1999) 1697-1710
33. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404 6781 (2000) 995-999
34. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 97 7 (2000) 3370-3375
35. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192 10 (2000) 1453-1466
36. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293 5537 (2001) 2111-2114
37. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15 2 (2001) 289-302
38. Shulga-Morskaya S., Dobles M., Walsh M.E., Ng L.G., MacKay F., Rao S.P., et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 173 4 (2004) 2331-2341
39. Sasaki Y., Casola S., Kutok J.L., Rajewsky K., and Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 173 4 (2004) 2245-2252
40. von Bulow G.U., van Deursen J.M., and Bram R.J. Regulation of the T-independent humoral response by TACI. Immunity 14 5 (2001) 573-582
41. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., et al. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2 7 (2001) 638-643
42. Seshasayee D., Valdez P., Yan M., Dixit V.M., Tumas D., and Grewal I.S. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18 2 (2003) 279-288
43. Melchers F., and Kincade P. Early B cell development to a mature, antigen-sensitive cell. In: Alt F.W., Honjo T., and Neuberger M. (Eds). Molecular Biology of B cells (2004), Elsevier Science, USA 101-126
44. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3 10 (2002) 958-965
45. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17 4 (2002) 515-524
46. Craxton A., Draves K.E., Gruppi A., and Clark E.A. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 202 10 (2005) 1363-1374
47. Mecklenbrauker I., Kalled S.L., Leitges M., Mackay F., and Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 431 7007 (2004) 456-461
48. Thompson J.S., Schneider P., Kalled S.L., Wang L., Lefevre E.A., Cachero T.G., et al. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med 192 1 (2000) 129-135
49. Pelletier M., Thompson J.S., Qian F., Bixler S.A., Gong D., Cachero T., et al. Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J Biol Chem 9 20 (2003) 5977-5983
50. Gong Q., Ou Q., Ye S., Lee W.P., Cornelius J., Diehl L., et al. Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy. J Immunol 174 2 (2005) 817-826
51. Schneider P., Takatsuka H., Wilson A., Mackay F., Tardivel A., Lens S., et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med 194 11 (2001) 1691-1697
52. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37 8 (2005) 829-834
53. Hsu B.L., Harless S.M., Lindsley R.C., Hilbert D.M., and Cancro M.P. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol 168 12 (2002) 5993-5996
54. Vora K.A., Wang L.C., Rao S.P., Liu Z.Y., Majeau G.R., Cutler A.H., et al. Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function. J Immunol 171 2 (2003) 547-551
55. Vugmeyster Y., Seshasayee D., Chang W., Storn A., Howell K., Sa S., et al. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys. Am J Pathol 168 2 (2006) 476-489
56. Thomas M.D., Kremer C.S., Ravichandran K.S., Rajewsky K., and Bender T.P. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23 3 (2005) 275-286
57. Halpern W.G., Lappin P., Zanardi T., Cai W., Corcoran M., Zhong J., et al. Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic and toxicologic effects. Toxicol Sci (2006)
58. Furie R., Stohl W., Ginzler E., Becker M., Mishra N., Chatham W., et al. Safety pharmacokinetic and pharmacodynamic results of a phase 1 single and double dose-escalation study of LymphoStat-B (human monoclonal antibody to BLyS) in SLE patients. Arthiris Rheumatism 48 Suppl. (2003) 377
59. Castigli E., Wilson S.A., Scott S., Dedeoglu F., Xu S., Lam K.P., et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 201 1 (2005) 35-39
60. Berland R., and Wortis H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20 (2002) 253-300
61. Tew J.G., Wu J., Fakher M., Szakal A.K., and Qin D. Follicular dendritic cells: beyond the necessity of T-cell help. Trends Immunol 22 7 (2001) 361-367
62. Rahman Z.S., Rao S.P., Kalled S.L., and Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med 198 8 (2003) 1157-1169
63. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201 9 (2005) 1375-1383
64. Priestley A, Beaston C, Lyngso B, Triolo A, Busby S, Broly H, et al. Safety, pharmacokinetics and pharmacodynamics of TACI-Ig in healthy volunteers. Paper presented at: 4th International Congress on Autoimmunity, Budapest, Hungary; 2004.
65. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcon G.S., Fessler B.J., et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166 1 (2001) 6-10
66. Cheema G.S., Roschke V., Hilbert D.M., and Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44 6 (2001) 1313-1319
67. Kern C., Cornuel J.F., Billard C., Tang R., Rouillard D., Stenou V., et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103 2 (2004) 679-688
68. Fu L., Lin-Lee Y.C., Pham L.V., Tamayo A., Youshimura L., Ford R.J., Constitutive NF-{kappa}B, and NFAT Activation Leads to Stimulation of The BLyS Survival Pathway in Aggressive B Cell Lymphomas. Blood (2006)
69. Elsawa S.F., Novak A.J., Grote D.M., Ziesmer S.C., Witzig T.E., Kyle R.A., et al. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. Blood 107 7 (2006) 2882-2888